Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Finemedix Co., Ltd. (387570:KRX), powered by AI.
Finemedix Co., Ltd. is currently trading at ₩7,180. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Finemedix Co., Ltd. on Alpha Lenz.
Finemedix Co., Ltd.'s P/E ratio is -1348.6.
“Finemedix Co., Ltd. trades at a P/E of -1348.6 (undervalued) with modest ROE of -0.1%. 3Y revenue CAGR of 11.1% highlights clear growth momentum.”
Ask for details →Finemedix Co., Ltd. is a company that operates within the healthcare and medical equipment industry. Its primary function is to develop and produce various medical devices and surgical instruments, which are essential for healthcare providers worldwide. The company's product range typically includes innovative solutions designed to improve patient care and enhance the capabilities of medical professionals. By focusing on high-quality manufacturing and advanced technology, Finemedix Co., Ltd. impacts sectors such as hospitals, medical research facilities, and clinics that require precise and reliable medical equipment. The company's role in the financial market is significant due to its contribution to the medical industry, which remains a critical component of global health systems. As medical technology evolves and demand for healthcare solutions continues to grow, Finemedix Co., Ltd. plays a pivotal role in advancing medical practices and supporting the healthcare infrastructure.
“Finemedix Co., Ltd. trades at a P/E of -1348.6 (undervalued) with modest ROE of -0.1%. 3Y revenue CAGR of 11.1% highlights clear growth momentum.”
Ask for details →Finemedix Co., Ltd. (ticker: 387570) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 70 employees. Market cap is $40.4B.
The current price is ₩7,180 with a P/E ratio of -1,348.56x and P/B of 1.57x.
ROE is -0.14% and operating margin is -0.29%. Annual revenue is $10.0B.